Nordson Corp. Stock
Nordson Corp. Stock
There is an upward development for Nordson Corp. compared to yesterday, with an increase of €3.00 (1.410%).
With 9 Buy predictions and not the single Sell prediction the community is currently very high on Nordson Corp..
As a result the target price of 261 € shows a positive potential of 20.55% compared to the current price of 216.5 € for Nordson Corp..
Pros and Cons of Nordson Corp. in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Nordson Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Nordson Corp. | 1.410% | -1.322% | -10.574% | 5.097% | -9.034% | 18.956% | - |
| Zurn Water Solutions Corp. | 0.710% | -3.401% | -3.401% | 35.238% | 6.767% | -29.703% | 18.605% |
| ITT Corp | -0.830% | -5.556% | -1.653% | 67.606% | 10.185% | 55.556% | 132.286% |
| John Bean Technologies Corp. | 2.370% | 2.367% | 4.217% | -13.500% | -4.420% | -28.512% | -6.141% |
Comments
Nordson Co. (NASDAQ: NDSN) had its price target lowered by analysts at DA Davidson from $315.00 to $295.00. They now have a "buy" rating on the stock.
Show more
Ratings data for NDSN provided by MarketBeat
Nordson Co. (NASDAQ: NDSN) had its price target lowered by analysts at Robert W. Baird from $303.00 to $272.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for NDSN provided by MarketBeat
Nordson Co. (NASDAQ: NDSN) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for NDSN provided by MarketBeat
News
Nordson Corporation Announces Agreement to Acquire Atrion Corporation, a Market Leader in Medical Infusion and Cardiovascular Technologies
Nordson Corporation (Nasdaq: NDSN) today announced that it has entered into a definitive agreement to acquire Atrion Corporation (Nasdaq: ATRI), a leader in proprietary medical infusion fluid
Nordson Corporation Reports Second Quarter Fiscal 2024 Results and Updates Annual Guidance
Nordson Corporation (Nasdaq: NDSN) today reported results for the fiscal second quarter ended April 30, 2024. Sales were $651 million, comparable to the prior year’s second quarter sales of $650
Nordson Corporation Declares Third Quarter Dividend for Fiscal Year 2024
Nordson Corporation (Nasdaq: NDSN) today announced that its board of directors declared a fiscal year 2024 third quarter cash dividend in the amount of $0.68 per common share, payable on June 4